Veracyte (VCYT) Total Debt Growth (1y) (2014 - 2026)
Veracyte (VCYT) Total Debt Growth (1y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 22.57% |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 48.73% |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | -20.41% |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | -4.01% |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 3.29% |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | -72.17% |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | -0.07% |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | -3.29% |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | -0.37% |
| 10 | Veracyte | 3.69 Bn | 3.39 Bn | 108.55 Mn | -95.07% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -95.07% |
| Mar 31, 2026 | -93.16% |
| Dec 31, 2025 | -92.16% |
| Sep 30, 2025 | 83.62% |
| Jun 30, 2025 | 82.57% |
| Mar 31, 2025 | 107.10% |
| Dec 31, 2024 | 539.10% |
| Sep 30, 2024 | 187.14% |
| Jun 30, 2024 | 118.76% |
| Mar 31, 2024 | 110.12% |
| Dec 31, 2023 | -63.40% |
| Sep 30, 2023 | -56.47% |
| Jun 30, 2023 | -52.90% |
| Mar 31, 2023 | 205.84% |
| Dec 31, 2022 | 544.19% |
| Sep 30, 2022 | 58.91% |
| Jun 30, 2022 | 66.15% |
| Mar 31, 2022 | -84.25% |
| Dec 31, 2021 | 39.14% |
| Sep 30, 2021 | 392.20% |